Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. intravenous dose
Show results for
Products
Services
Applications

Companies

News
Articles

Refine by
Date

  • Older

Intravenous Dose Articles & Analysis

4 articles found

Conceptual Considerations for Device-Based Therapy in Acute Decompensated Heart Failure

Conceptual Considerations for Device-Based Therapy in Acute Decompensated Heart Failure

In both the Ultrafiltration versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Congestive Heart Failure (UNLOAD)47 and Aquapheresis versus Intravenous Diuretics and Hospitalization for Heart Failure (AVOID-HF)48 trials, decongestion with aquaphoresis resulted in increased net fluid loss and led to a reduction in HF readmissions ...

BySecond Heart Assist, Inc.


Rani Therapeutics Debuts on the Nasdaq: What uou should know About the Biopharma

Rani Therapeutics Debuts on the Nasdaq: What uou should know About the Biopharma

Rani, A Platform Technology Company: Rani's proprietary platform technology, the RaniPill capsule, intends to replace subcutaneous or intravenous injections of biologics with oral dosing. RaniPill helps convert injectable biologic drugs such as TNF-alpha inhibitors, interleukin antibodies and basal insulin, among others, into pills. ...

ByRani Therapeutics


FIGO good clinical practice paper: management of the second stage of labor

FIGO good clinical practice paper: management of the second stage of labor

Augment contractions with an intravenous oxytocin infusion during the second stage—when necessary, and only where safe to do so—if contractions have become infrequent, providing the fetal heart rate remains normal. ...

ByMedinvent Ltd


Regeneron’s High Profile Success? Demand for COVID-19 prophylactics – what role for Pichia expression technology to assist access

Regeneron’s High Profile Success? Demand for COVID-19 prophylactics – what role for Pichia expression technology to assist access

In this context, we review here the manufacturing costs at scale for nanobodies, and ask whether their production costs are really cheaper than CHO-produced mAbs. An inhaled dose of COVID-19 neutralising nanobodies for prevention or early treatment of infection is the type of substantial development that can be catapulted to reality in times as these. ...

ByBiopharm Services Limited

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT